[VIDEO] Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
Gemma Rogers, Communications Director at Oxford Pharmagenesis, discusses a study on clinical trial transparency.
[VIDEO] Open access policies of leading medical journals: a cross-sectional study
Tim Ellison, Senior Medical Writer at Oxford PharmaGenesis, discusses a study into the open access policies of leading medical journals
[VIDEO] Professional medical writing support and the quality, ethics and timeliness of clinical trial reporting: a systematic review
Obaro Evuarherhe, Principal Consultant at Oxford PharmaGenesis, discusses professional medical writing support and the quality, ethics and timeliness of clinical trial reporting.
[VIDEO] Good Practice for Conference Abstracts and Presentations: GPCAP
Jackie Marchington, Director of Global Operations at Caudex, discusses good practice for conference abstracts and presentations
The impact factor holds its grip on academia
Researchers continue to use the impact factor as a metric for their career progression, but is it a matter of misconstrued peer pressure?
The link between data sharing and citation counts
An analysis of data sharing statements reveals that open data may lead to a citation advantage.
Advantages and challenges of narrative reviews and Delphi consensus initiatives
Help and guidance for writing narrative reviews and Delphi consensus statements.
Plan S version 2: the right approach to full open access?
Following the revised guidance on Plan S, Bernd Pulverer questions whether cOAlition S is making the most of the opportunity to push for open science.
Peer Review Week 2019 is here!
Find out how to get involved in this year’s activities on #QualityinPeerReview.
MPIP: Overcoming barriers to open access for industry
A new tool from MPIP provides easily accessible information on open access options for industry-funded research.
Defining the role of the peer reviewer
The tasks and responsibilities of peer reviewers are examined as a step towards reaching a consensus on their role in biomedical publishing
Can you spot a predatory conference?
Ruairi Mackenzie provides a personal account of attending a “fake” conference run by Conference Series in a recent article for Technology Networks.
How much can a single paper affect journal impact factor?
A recent preprint sheds light on just how volatile journal impact factors can be.
Does professional medical writing support impact the quality, ethics and timeliness of clinical trial reporting?
Findings of a systematic review show working with professional medical writers positively affects measures of quality, ethics and timeliness.
ISMPP poll: non-disclosure of possible COI by author ‒ what would you do?
The MAP newsletter explores an issue faced by medical publication professionals.
CBI’s Medical Publications and Communications Forum
Join CBI to discuss challenges, innovations and best practice in medical publishing and communications.